Paychex
PAYX
101.55
+0.53
+0.52%
Paychex
US · PAYX
#600 by market cap
Listed 1970
101.55
+0.53
+0.52%
Live - 5344 symbols - heartbeat 120s ago
· 2026-10-08 06:02
Pre-market
102.46
+0.90%
After-hours
101.55
0.00%
Overnight
101.56
+0.01%
- Market cap
- 36.15B
- P/E (TTM)i
- 20.15
- P/Bi
- 9.76
- EPSi
- 4.89
- Div yieldi
- 4.47%
- 52W posi
- 41%
Reader sentiment
Are you bullish or bearish on PAYX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.95, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +16.88% YoY
Margins
- Gross margin
- 74.29%
- Operating margin
- 38.55%
- Net margin
- 27.03%
Key ratios & quality
- PEG ratioi
- 4.84
- Altman Z-Scorei
- 2.95
PEG uses trailing P/E against the 3-year net income growth rate (4.17%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.77B | 4.04B | 4.06B | 4.61B | 5.01B | 5.28B | 5.57B | 6.51B |
| Gross profit | 2.59B | 2.76B | 2.79B | 3.26B | 3.55B | 3.80B | 4.03B | 4.84B |
| Selling & admin expenses | 1.22B | 1.30B | 1.32B | 1.42B | 1.52B | 1.62B | 1.82B | 2.33B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.37B | 1.46B | 1.46B | 1.84B | 2.03B | 2.17B | 2.21B | 2.51B |
| Pretax profit | 1.37B | 1.44B | 1.43B | 1.82B | 2.05B | 2.22B | 2.18B | 2.31B |
| Tax | 333.60M | 339.00M | 336.70M | 431.80M | 490.90M | 527.60M | 518.60M | 550.80M |
| Net profit | 1.03B | 1.10B | 1.10B | 1.39B | 1.56B | 1.69B | 1.66B | 1.76B |
| Basic EPS | 3 | 3 | 3 | 4 | 4 | 5 | 5 | 5 |
| Diluted EPS | 2.86 | 3.04 | 3.03 | 3.84 | 4.30 | 4.67 | 4.58 | 4.89 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Revenue | 1.43B | 1.54B | 1.56B | 1.81B | 1.61B | 1.63B |
| Gross profit | 1.03B | 1.13B | 1.15B | 1.38B | 1.19B | 1.20B |
| Selling & admin expenses | 602.30M | 584.30M | 573.50M | 585.70M | 583.50M | 581.20M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 431.10M | 541.90M | 571.90M | 792.00M | 604.70M | 619.20M |
| Pretax profit | 389.30M | 497.50M | 520.20M | 739.00M | 554.20M | 565.00M |
| Tax | 92.10M | 113.70M | 124.80M | 178.70M | 133.60M | 135.30M |
| Net profit | 297.20M | 383.80M | 395.40M | 560.30M | 420.60M | 429.70M |
| Basic EPS | 1 | 1 | 1 | 2 | 1 | 1 |
| Diluted EPS | 0.82 | 1.06 | 1.10 | 1.56 | 1.17 | 1.21 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 5.68B | 5.46B | 6.17B | 6.58B | 7.53B | 7.25B | 8.92B | 8.61B |
| Cash & ST investments | 712.60M | 932.40M | 1.03B | 1.22B | 1.60B | 1.50B | 1.66B | 1.12B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 8.68B | 8.55B | 9.23B | 9.64B | 10.55B | 10.38B | 16.56B | 16.17B |
| Total current liabilities | 4.85B | 4.43B | 4.94B | 5.27B | 5.81B | 5.31B | 6.96B | 6.84B |
| Short-term debt | -- | 5.10M | 7.40M | 8.70M | 10.20M | 18.70M | 418.40M | -- |
| Long-term debt | 796.40M | 796.80M | 797.30M | 797.70M | 798.20M | 798.60M | 4.55B | 4.56B |
| Total liabilities | 6,056,500,000.00 | 5,769,300,000.00 | 6,279,200,000.00 | 6,550,000,000.00 | 7,053,200,000.00 | 6,582,100,000.00 | 12,436,100,000.00 | 12,439,400,000.00 |
| Total equity | 2.62B | 2.78B | 2.95B | 3.09B | 3.49B | 3.80B | 4.13B | 3.74B |
| Retained earnings | 1.41B | 1.43B | 1.45B | 1.67B | 2.02B | 2.21B | 2.28B | 1.81B |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Total current assets | 8.92B | 9.04B | 8.91B | 9.93B | 8.61B | 8.09B |
| Cash & ST investments | 1.66B | 1.67B | 1.52B | 1.78B | 1.12B | 934.20M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 16.56B | 16.66B | 16.52B | 17.51B | 16.17B | 15.66B |
| Total current liabilities | 6.96B | 7.13B | 7.04B | 7.88B | 6.84B | 6.34B |
| Short-term debt | 418.40M | 418.40M | 418.10M | 400.00M | -- | -- |
| Long-term debt | 4.55B | 4.55B | 4.55B | 4.55B | 4.56B | 4.56B |
| Total liabilities | 12,436,100,000.00 | 12,692,400,000.00 | 12,638,800,000.00 | 13,497,800,000.00 | 12,439,400,000.00 | 11,955,200,000.00 |
| Total equity | 4.13B | 3.97B | 3.88B | 4.01B | 3.74B | 3.71B |
| Retained earnings | 2.28B | 2.07B | 1.95B | 2.05B | 1.81B | 1.79B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.27B | 1.44B | 1.26B | 1.59B | 1.71B | 1.90B | 1.90B | 2.56B |
| Depreciation & amortization | 181.50M | 209.70M | 192.00M | 191.80M | 176.60M | 176.50M | 209.50M | 442.60M |
| Free cash flow | 1.15B | 1.31B | 1.14B | 1.46B | 1.56B | 1.74B | 1.71B | 2.32B |
| Dividends paid | -826.80M | -889.40M | -908.70M | -999.60M | -1.18B | -1.32B | -1.45B | -1.59B |
| Stock buybacks / issuance | -56.90M | -171.90M | -155.70M | -145.20M | 0 | -169.20M | -104.50M | -611.00M |
| Ending cash balance | 935.20M | 1.66B | 1.82B | 928.40M | 2.13B | 1.90B | 2.73B | 1.48B |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Operating cash flow | 343.80M | 718.40M | 444.90M | 812.50M | 580.90M | 413.50M |
| Depreciation & amortization | 85.70M | 109.30M | 109.10M | 111.00M | 113.20M | 109.80M |
| Free cash flow | 283.30M | 662.50M | 382.80M | 761.50M | 515.00M | 357.40M |
| Dividends paid | -389.30M | -389.10M | -387.90M | -388.00M | -424.60M | -424.10M |
| Stock buybacks / issuance | 0 | -160.10M | -126.50M | -75.00M | -249.40M | 0 |
| Ending cash balance | 2.73B | 1.63B | 1.87B | 2.92B | 1.48B | 655.90M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 44.55 | 40.66 | 38.31 | 46.17 | 47.35 | 46.35 | 41.80 | 44.77 |
| ROA %i | 12.82 | 12.75 | 12.35 | 14.77 | 15.43 | 16.15 | 12.30 | 10.75 |
| ROIC %i | 33.28 | 31.50 | 29.85 | 36.32 | 37.18 | 36.69 | 24.35 | 22.46 |
| 5-year avg ROE %i | 41.85 | 42.40 | 41.88 | 42.57 | 42.81 | 43.77 | 44.00 | 45.29 |
| EBIT margin %i | 36.73 | 36.53 | 36.24 | 40.36 | 41.64 | 42.73 | 40.94 | 39.63 |
| FCF / sales %i | 30.42 | 32.52 | 28.24 | 29.77 | 31.08 | 32.90 | 30.67 | 35.65 |
| Current ratioi | 1.17 | 1.23 | 1.25 | 1.25 | 1.30 | 1.37 | 1.28 | 1.26 |
| Quick ratioi | 0.32 | 0.39 | 0.42 | 0.48 | 0.52 | 0.59 | 0.52 | 0.49 |
| Debt / assetsi | 9.33 | 10.51 | 9.72 | 9.15 | 8.21 | 8.34 | 30.32 | 28.49 |
| LT debt / equityi | 30.90 | 32.13 | 30.18 | 28.28 | 24.49 | 22.30 | 111.53 | 123.38 |
| Interest coveragei | 78.73 | 38.04 | 41.06 | 50.85 | 56.81 | 60.46 | 21.64 | 9.57 |
| Revenue CAGR (3Y) %i | 8.52 | 8.62 | 6.30 | 6.92 | 7.41 | 9.17 | 6.51 | 9.15 |
| Net income CAGR (3Y) %i | 10.98 | 9.94 | 3.35 | 10.42 | 12.35 | 15.49 | 5.97 | 4.17 |
| FCF CAGR (3Y) %i | 7.63 | 14.90 | 0.58 | 8.25 | 5.96 | 14.99 | 5.49 | 14.10 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| ROE %i | 41.80 | 41.27 | 40.89 | 40.26 | 44.77 | 47.06 |
| ROA %i | 12.30 | 11.89 | 11.79 | 11.39 | 10.75 | 11.17 |
| ROIC %i | 24.35 | 24.57 | 24.96 | 25.52 | 22.46 | 23.27 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 40.94 | 39.36 | 38.38 | 38.12 | 39.63 | 40.06 |
| FCF / sales %i | 30.67 | 32.13 | 33.08 | 33.00 | 35.65 | 30.54 |
| Current ratioi | 1.28 | 1.27 | 1.27 | 1.26 | 1.26 | 1.28 |
| Quick ratioi | 0.52 | 0.52 | 0.50 | 0.49 | 0.49 | 0.52 |
| Debt / assetsi | 30.32 | 30.14 | 30.49 | 28.63 | 28.49 | 29.51 |
| LT debt / equityi | 111.53 | 115.93 | 119.04 | 114.94 | 123.38 | 124.70 |
| Interest coveragei | 21.64 | 13.90 | 10.38 | 8.99 | 9.57 | 9.93 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 06:02:21 · For reference only, not investment advice and not tailored to your situation.